Glioma stem cell research for the development of immunotherapy

Advances in Experimental Medicine and Biology

Volumn 746, Issue , 2012, Pages 216-225

  Xu, Qijin ^a   Yuan, Xiangpeng ^a   Yu, John S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STEM CELL ANTIGEN; CANCER VACCINE; CELL ANTIGEN; DENDRITIC CELL VACCINE; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 4; PROSTATE STEM CELL ANTIGEN; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER INHIBITION; CANCER STEM CELL; CANCER SURVIVAL; DENDRITIC CELL; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; DRUG TOLERABILITY; GLIOBLASTOMA; GLIOMA STEM CELL; HUMAN; IMMUNOREGULATION; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; STEM CELL GENE THERAPY; STEM CELL RESEARCH; TUMOR IMMUNITY;

BRAIN NEOPLASMS; DENDRITIC CELLS; GENE THERAPY; GLIOMA; HUMANS; IMMUNOTHERAPY; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION;

EID: 84862985561     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3146-6_17     Document Type: Article

References (42)

1. Yuan X, Curtin J, Xiong Y et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004; 23(58):9392-9400. (Pubitemid 40069671)
2. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004; 432(7015):396-401. (Pubitemid 39551674)
3. Bruggeman SW, Hulsman D, Tanger E et al. Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 2007; 12(4):328-341. (Pubitemid 47539307)
4. OBrien CA, Pollett A, Gallinger S et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445(7123):106-110. (Pubitemid 46067310)
5. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445(7123):111-115. (Pubitemid 46067311)
6. Liao MJ, Zhang CC, Zhou B et al. Enrichment of a population of mammary gland cells that form mammospheres and have in vivo repopulating activity. Cancer Res 2007; 67(17):8131-8138. (Pubitemid 47395148)
7. Karnoub AE, Dash AB, Vo AP et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449(7162):557-563. (Pubitemid 47525152)
8. Bao S, Wu Q, McLendon RE et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444(7120):756-760. (Pubitemid 44949604)
9. Lee EJ, Russell T, Hurley L et al. Pituitary transcription factor-1 induces transient differentiation of adult hepatic stem cells into prolactin-producing cells in vivo. Mol Endocrinol 2005; 19(4):964-971. (Pubitemid 40397060)
10. Furnari FB, Huang HJ, Cavenee WK. Genetics and malignant progression of human brain tumours. Cancer Surv 1995; 25:233-275.
11. Wright MH, Calcagno AM, Salcido CD et al. Brca1 breast tumors contain distinct CD44/CD24- and CD133 cells with cancer stem cell characteristics. Breast Cancer Res 2008; 10(1):R10.
12. Folkins C, Man S, Xu P et al. Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res 2007; 67(8):3560-3564. (Pubitemid 46762138)
13. Wicha MS. Cancer stem cell heterogeneity in hereditary breast cancer. Breast Cancer Res 2008; 10(2):105.
14. Shmelkov SV, Butler JM, Hooper AT et al. CD133 expression is not restricted to stem cells and both CD133 and CD133- metastatic colon cancer cells initiate tumors. J Clin Invest 2008; 118(6):2111-2120. (Pubitemid 351872330)
15. Piccirillo SG, Reynolds BA, Zanetti N et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006; 444(7120):761-765. (Pubitemid 44949605)
16. Phillips HS, Kharbanda S, Chen R et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression and resemble stages in neurogenesis. Cancer Cell 2006; 9(3):157-173. (Pubitemid 43357943)
17. Dahmane N, Sanchez P, Gitton Y et al. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 2001; 128(24):5201-5212. (Pubitemid 34083045)
18. Katayam M, Yoshida K, Ishimori H et al. Patched and smoothened mRNA expression in human astrocytic tumors inversely correlates with histological malignancy. J Neurooncol 2002; 59(2):107-115. (Pubitemid 35021558)
19. Mellinghoff IK, Wang MY, Vivanco I et al. Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med 2005; 353(19):2012-2024. (Pubitemid 41609094)
20. Bachoo RM, Maher EA, Ligon KL et al. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002; 1(3):269-277. (Pubitemid 41039151)
21. Fan QW, Knight ZA, Goldenberg DD et al. A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 2006; 9(5):341-349. (Pubitemid 43668732)
22. Jackson EL, Garcia-Verdugo JM, Gil-Perotin S et al. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 2006; 51(2):187-199. (Pubitemid 44063617)
23. Ligon KL, Huillard E, Mehta S et al. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron 2007; 53(4):503-517. (Pubitemid 46216748)
24. Clement V, Sanchez P, de Tribolet N et al. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal and tumorigenicity. Curr Biol 2007; 17(2):165-172. (Pubitemid 46107823)
25. Choe G, Horvath S, Cloughesy TF et al. Analysis of the phosphatidylinositol 3-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res 2003; 63(11):2742-2746. (Pubitemid 36667143)
26. Backman SA, Ghazarian D, So K et al. Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci USA 2004; 101(6):1725-1730. (Pubitemid 38234221)
27. Cully M, Elia A, Ong SH et al. grb2 heterozygosity rescues embryonic lethality but not tumorigenesis in pten/- mice. Proc Natl Acad Sci USA 2004; 101(43):15358-15363. (Pubitemid 39441546)
28. Okumura K, Zhao M, Depinho RA et al. Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor. Proc Natl Acad Sci USA 2005; 102(8):2703-2706. (Pubitemid 40299856)
29. Dirks PB. Glioma migration: clues from the biology of neural progenitor cells and embryonic CNS cell migration. J Neurooncol 2001; 53(2):203-212. (Pubitemid 33034692)
30. Aboody KS, Brown A, Rainov NG et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000; 97(23):12846-12851.
31. Benedetti S, Pirola B, Pollo B et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2000; 6(4):447-450. (Pubitemid 30208163)
32. Ehtesham M, Kabos P, Gutierrez MA et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 2002; 62(24):7170-7174. (Pubitemid 36025232)
33. Ehtesham M, Kabos P, Kabosova A et al. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 2002; 62(20):5657-5663. (Pubitemid 35204717)
34. Yuan X, Hu J, Belladonna ML et al. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res 2006; 66(5):2630-2638.
35. Hu J, Yuan X, Belladonna ML et al. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells. Cancer Res 2006; 66(17):8887-8896. (Pubitemid 44449207)
36. Luptrawan A, Liu G, Yu JS. Dendritic cell immunotherapy for malignant gliomas. Rev Recent Clin Trials 2008; 3(1):10-21. (Pubitemid 351267023)
37. Yamanaka R. Cell- and peptide-based immunotherapeutic approaches for glioma. Trends Mol Med 2008; 14(5):228-235.
38. Ehtesham M, Yuan X, Kabos P et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 2004; 6(3):287-293. (Pubitemid 38657085)
39. Liau LM, Black KL, Martin NA et al. Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report. Neurosurg Focus 2000; 9(6):e8.
40. Yu JS, Wheeler CJ, Zeltzer PM et al. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration. Cancer Res 2001; 61(3):842-847. (Pubitemid 32175145)
41. Yu JS, Liu G, Ying H et al. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 2004; 64(14):4973-4979. (Pubitemid 38924545)
42. Lee J, Kotliarova S, Kotliarov Y et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9(5):391-403. (Pubitemid 43668737)